1st Quarter - Report
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for CHIMERIX, INC.
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
MCM development & procurement process; S. 415, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.